Literature DB >> 18056430

Nuclear factor-kappaB, an unappreciated tumor suppressor.

Fei Chen1, Vince Castranova.   

Abstract

The notion that nuclear factor-kappaB (NF-kappaB) is a tumor-promoting transcription factor has become a widely accepted dogma in biology. However, recent findings suggest an inhibitory role for NF-kappaB in carcinogenesis and tumorigenesis. Although the tumor suppressor-like effect of NF-kappaB remains to be rigorously established by further studies using cellular and animal models, these latest findings warrant caution with respect to blockage of NF-kappaB activation as a broad strategy in treating cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056430     DOI: 10.1158/0008-5472.CAN-07-1576

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression.

Authors:  Feiyan Liu; Kankana Bardhan; Dafeng Yang; Muthusamy Thangaraju; Vadivel Ganapathy; Jennifer L Waller; Georgia B Liles; Jeffrey R Lee; Kebin Liu
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.

Authors:  Katarina Ochodnicka-Mackovicova; Mahnoush Bahjat; Timon A Bloedjes; Chiel Maas; Alexander M de Bruin; Richard J Bende; Carel J M van Noesel; Jeroen E J Guikema
Journal:  Blood       Date:  2015-07-07       Impact factor: 22.113

3.  Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells.

Authors:  Thangaiyan Rabi; Sanjeev Shukla; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2008-12       Impact factor: 4.784

4.  Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation.

Authors:  Xiaolin Hu; Mary A Zimmerman; Kankana Bardhan; Dafeng Yang; Jennifer L Waller; Georgia B Liles; Jeffrey R Lee; Raphael Pollock; Dina Lev; Carl F Ware; Ellen Garber; Veronique Bailly; Jeffrey L Browning; Kebin Liu
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

5.  Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth.

Authors:  Padmamalini Kannan-Thulasiraman; Darcie D Seachrist; Ganapati H Mahabeleshwar; Mukesh K Jain; Noa Noy
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

6.  Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Authors:  Sima Z Torabian; David de Semir; Mehdi Nosrati; Sepideh Bagheri; Altaf A Dar; Sylvia Fong; Yong Liu; Scot Federman; Jeff Simko; Chris Haqq; Robert J Debs; Mohammed Kashani-Sabet
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

Review 7.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

8.  Analysis of the IKKbeta/NF-kappaB signaling pathway during embryonic angiogenesis.

Authors:  Yanjun Hou; Fu Li; Michael Karin; Michael C Ostrowski
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

Review 9.  Glycogen synthase kinase 3beta (GSK3beta) in tumorigenesis and cancer chemotherapy.

Authors:  Jia Luo
Journal:  Cancer Lett       Date:  2008-07-07       Impact factor: 8.679

10.  Identification of a small molecule inhibitor of serine 276 phosphorylation of the p65 subunit of NF-kappaB using in silico molecular docking.

Authors:  Mary Law; Patrick Corsino; Nicole Teoh Parker; Brian K Law
Journal:  Cancer Lett       Date:  2009-11-11       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.